Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.
about
Cloning of a phospholipase A2-activating proteinMultiple roles of TNF super family members in corpus luteum functionLPS-challenged TNFα production, prostaglandin secretion, and TNFα/TNFRs expression in the endometrium of domestic cats in estrus or diestrus, and in cats with pyometra or receiving medroxyprogesterone acetateActivation of cellular phospholipase A2 by Clostridium difficile toxin B.Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury.Cholera toxin induces synthesis of phospholipase A2-activating protein.Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disordersTumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells.Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis.Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteinsThe molecular action of tumor necrosis factor-alpha.Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosisIntravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.G protein regulation of phospholipase A2.Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis.Serum phospholipase--regulatory and pathophysiological aspects.Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties.Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor.Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D.Phospholipase A2 and arthritis.TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite.Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.Change of membrane potential is not required for the tumour necrosis factor-alpha mediated cytotoxicity.Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C.Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.Interleukin 1- and tumor necrosis factor-stimulation of prostaglandin E2 synthesis in MDCK cells, and potentiation of this effect by cycloheximide.Vulnerability of vascular endothelium in lipopolysaccharide toxicity: effect of (acyl) carnitine on endothelial stability.Phospholipase A2--regulation and inhibition.Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells.Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.Effects of tumour necrosis factor-alpha on the coronary circulation of the rat isolated perfused heart: a potential role for thromboxane A2 and sphingosine.Role of a membrane-associated serine esterase in the oxidant activation of phospholipase A2 by t-butyl hydroperoxide.Somatostatin reduces the levels of tumor necrosis factor alpha in a rat model of endotoxemia induced by lipopolysaccharide.Ca(2+)-independent arachidonic acid release by vascular endothelium requires protein synthesis de novo.Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists.Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis.Preferential distribution of group-II-like phospholipase A2 in mononuclear phagocytic cells in rat spleen and liver.
P2860
Q24564629-BA8888CE-1C1F-46B3-8A69-418D0245DC57Q24798739-7D000877-D2F6-45E7-BC1E-43150B31A3D2Q33853058-24D672D3-C66E-4AB4-9BC6-768E05355915Q34350581-910D4AB0-1F3B-4E9C-ACFF-41F1D5CEE44CQ35094362-1771D4BF-3EED-4B49-9B2C-7DDBB2B2DAAEQ35497868-480F39A2-D52E-4055-9A62-A42A8FEDA20BQ35598961-EDF72721-5FDD-4B91-AD8B-96DF66FAFD82Q35915801-8AFE47DD-C77D-446F-9FD6-09FA3A24DA75Q36078622-DC421630-F3D6-4123-9E9A-9064B6A0E24AQ36300832-56BB04C8-18E9-4B6D-8881-7637C749EB3CQ36356510-4823351B-2ACB-4586-B185-D77AB1C691CAQ36436880-3E188133-22C6-4F39-9666-467B609EA3E9Q36765200-BAC53655-3348-498C-B1D9-D53B605F67E9Q37354891-C0138656-0896-4A80-9A5A-9BFF2D9B31FAQ37355971-5A8DD167-D03F-4CD6-8066-0931CC483A17Q37478120-AAFD88DE-A1F1-43C9-9307-95E635E89C05Q38238330-56A16B4A-8B13-437B-9AC0-5D89CDC58085Q38391987-E52AC754-7C1E-4877-9BB0-5F61C91610B1Q38610981-6CB5A6DF-118A-4F77-A929-35213416BA3CQ40346861-B5A14C10-E3EB-4977-A494-9AF2F1D99841Q40703415-583B7A1E-B6FA-4F6A-BAE3-5FA17BC535E3Q40840187-FD8DDAA3-23E8-4574-B1D7-FB4AF6A2F8B5Q40874634-1D476C5C-0B38-489A-A860-FA5C6387F63EQ41079611-0A5D1A03-CFAF-4CE3-874F-F0F73CEDF15AQ41474368-597532F1-FBA1-481E-AC80-9E35EC8F3454Q41588020-E36B671C-3D1C-4823-ADBD-5EA72F8A3D25Q41659611-0358FEFE-150B-42D8-AC6D-ADAF32B54E7FQ41711674-32219E1E-8DB5-4CBC-9B86-5C762F8381C4Q41750791-BA49D7F4-2345-4287-A161-FD0379FA82AEQ41888072-61C8BC77-8A94-42FD-A2C2-8C8C261A2489Q41946266-3F823E5D-CA7D-4DE9-8698-BEBAC2EAF1A7Q42006207-06B9295E-DA54-45B8-A523-3A0DD831C2BBQ42117732-F53DABB7-782E-476B-AA58-02C1E073075AQ42175598-03A062BA-5FA5-4FFC-B915-C83733FB9BB1Q42256886-F9DE5284-961A-4549-9E02-D543AED126D6Q42514818-4869ED91-5B92-4FDA-9729-A0198EF6A721Q42834828-8BCE8FC8-21F9-4CBB-B53E-C68FF5F6179AQ42835304-52F24CA0-783F-4B55-AB2F-23C499F4973FQ43985692-2C091330-F694-4684-84A3-6D789C09769FQ44358726-518D9BAC-2099-4FCC-AB09-A9DC47F2EE64
P2860
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@ast
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@en
type
label
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@ast
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@en
prefLabel
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@ast
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@en
P2093
P2860
P356
P1433
P1476
Tumour necrosis factor (cachec ...... protein in endothelial cells.
@en
P2093
J S Bomalaski
S T Crooke
P2860
P304
P356
10.1042/BJ2500125
P407
P577
1988-02-01T00:00:00Z